Journals / Respiratory Case Reports / 2018 / Cilt: 7 - Sayı: 3

Sertraline Related Pulmonary Disease

Sertralin İlişkili Akciğer Hastalığı

Pages
162–165
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As drug-related interstitial lung disease is rare, this case is presented as a contribution to the literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:It has been reported that 2.5% to 3% of interstitial lung diseases are related to prescription drugs.
📊
Key Findings & Data:Drugs can demonstrate side effects in all components of the respiratory system.
💡
Conclusion & Impact:As drug-related interstitial lung disease is rare, this case is presented as a contribution to the literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

It has been reported that 2.5% to 3% of interstitial lung diseases are related to prescription drugs. Drugs can demonstrate side effects in all components of the respiratory system. A 68-year-old woman was admitted to the department of respiratory diseases with a history of a cough and fever present for 2 weeks. A physical examination revealed crackles in the bilateral lower zones of the respiratory system. She had a history of using sertraline for depression. Based on the results of the clinical evaluation, radiological imaging, and laboratory findings, the patient was diagnosed with interstitial pulmonary disease emerging as a side effect of prescription drug use. As drug-related interstitial lung disease is rare, this case is presented as a contribution to the literature.

Özet

İnterstisyel akciğer hastalıklarının %2,5-3’ünün ilaçlarla ilişkili olarak ortaya çıktığı bildirilmektedir. İlaçlar, solunum sisteminin tüm komponentlerinde, yan etkileri gösterebilmektedirler. Altmış sekiz yaşında kadın hasta 2 haftadır olan öksürük ve ateş yakınmaları ile solunum hastalıkları polikliniğine başvurdu. Fizik muayenesinde, solunum sisteminde bilateral alt zonlarda raller duyuldu. Özgeçmişinde depresyon nedeniyle sertralin kullanma öyküsü vardı. Yapılan klinik değerlendirme, radyolojik görüntüleme ve laboratuvar neticelerin sonunda hastaya ilaçlara bağlı interstisyel akciğer hastalığı tanısı kondu. İlaçlara bağlı interstisyel akciğer hastalıkları nadir görüldüğünden literatüre katkı sağlamak amacıyla olguyu sunuyoruz.

🔖

Cite This Article

UZER, F., ÖĞÜŞ, A. C. (2018). Sertraline Related Pulmonary Disease. Respiratory Case Reports, Cilt: 7 - Sayı: 3, 162–165. https://ajindex.com/articles/302582

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Türker H. İlaçlara bağlı diffüz parankimal akciğer hastalıkları. In: Tabak L, Kumbasar ÖÖ (eds). Diffüz Parankimal Akciğer Hastalıkları. Toraks Kitapları. 2013; 17: 283-94
  2. Schwaiblmair M, Behr W, Haeckel T, Märkl B, Foerg W, Berghaus T. Drug induced interstitial lung disease. Open Respir Med J 2012; 6:63-74. [CrossRef] 3. Şenyiğit A. İlaçlarla ilişkili interstisyel akciğer hastalıkları. Güncel Göğüs Hastalıkları Serisi 2014; 2: 394-401
  3. Camus P, Fanton A, Bonniaud P, Camus C, Foucher P. Interstitial lung disease induced by drugs and radiation. Respiration 2004; 71:301–26. [CrossRef] 5. Ryrfeldt A. Drug-induced inflammatory responses to the lung. Toxicol Lett 2000; 112–113:171–6
  4. Torok NI, Donaldson BL, Taji J, Abugiazya A, Assaly R. Diffuse alveolar damage and recurrent respiratory failure secondary to Sertraline. Am J Ther 2012; 19:e132–5. [CrossRef] 7. Salcedo Mingoarranz AL, Puebla Villaescusa A, De Agustín Sierra L, Ramírez Cruz S, Hidalgo Correas FJ, García Díaz B. Lung infiltrates associated with sertraline administration. Farm Hosp 2016; 40:624-6
  5. Simpson AB, Paul J, Graham J, Kaye SB. Fatal bleomycin pulmonary toxicity in the west of Scotland 1991-95: a review of patients with germ cell tumours. Br J Cancer 1998; 78:1061-6. [CrossRef] 9. Cockerill FR, Wilson WR, Carpenter HA, Smith TF, Rosenow EC. Open lung biopsy in immunocompromised patients. Arch Intern Med 1985; 145:1398-404. [CrossRef]